Jack A. Khattar, President, CEO at SUPERNUS PHARMACEUTICALS, INC. (SUPN), sold 50,892 shares at $40.03 ($2.0M) on 2023-01-17, disclosed to the SEC on 2023-01-19.
Open-market sale of $2.0M SUPN by President, CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $40.03 | 25,446 | $1.0M | 50.0% |
| 2 | $40.03 | 25,446 | $1.0M | 50.0% |
| Total | $40.03 avg | 50,892 | $2.0M | 100% |
| Filing → |
| SUPN | SELL | 2025-10-03 | $183K | — | Filing → |
| SUPN | SELL | 2025-10-02 | $3.9M | — | Filing → |
| SUPN | SELL | 2025-10-01 | $414K | — | Filing → |